🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 629294109
- Market Cap
- Micro Cap · $48 Million
- Previous Name
- Nitinol Medical Technologies, Inc.
Business: NMT Medical designs, develops and markets proprietary implant technologies that allow interventional cardiologists to treat cardiac sources of stroke and other potential brain attacks through minimally invasive, catheter-based procedures. NMT Medical is investigating the potential connection between a common cardiac defect called a patent foramen ovale (PFO) and brain attacks such as stroke, transient ischemic attacks (TIA's) and migraine headaches. A PFO can allow venous blood, unfiltered by the lungs, to enter the arterial circulation of the brain possibly triggering a cerebral event or brain attack. NMT is a leader in designing and developing implants to seal the PFO defect in a minimally invasive, catheter-based procedure performed by the interventional cardiologist.
Company Contact
- CEO
- John E. Ahern
- CFO
- Richard E. Davis
- Headquarters
- 27 Wormwood Street, Boston, MA 02210
- Phone
- 617-737-0930 · Toll-Free 800-666-6484
- Fax
- 617-737-0924
- Investor Relations
- Richard E. Davis · 617-737-0930 · investorrelations@nmtmedical.com